Tuesday, November 10, 2020 - noon to 1:15 p.m.
UNH Franklin Pierce School of Law
Register now: https://unh.zoom.us/meeting/register/tJIsdO-vrjkpH9e9aFm8pPO8VqHMhxyHRG7_
UNH School of Law Health Law & Policy Programs and the Franklin Pierce Center for Intellectual Property Present: The UNH bioInnovation Speaker Series Webinar
Please Join Ekaterina Galkina-Cleary, Ph.D and Fred Ledley, M.D. from Bentley University’s Center for the Integration of Science and Industry, to discuss their recent work on the government’s investments in pharmaceutical innovation, the enabling role played by public sector science, and the relative risks and returns of public and private sector investments in new medicines. Their research shows that the scale of public sector investments in new medicines approach those of the private sector, raising questions about how public investment in new drugs should be recognized in policy aimed at promoting innovation and protecting access, availability, and affordability of new medicines. Moderated by Adjunct Professor in bioInnovation, Bruce Leicher.
What is the role of NIH funding in bioinnovation, drug discovery and development?
How does NIH funding de-risk and reduce the cost of private sector investment in drug development?
Does the current Bayh-Dole Regulatory regime capture the value of government funded research and protect the public interest?
What role should the government play in drug pricing, particularly for COVID-19 drugs and vaccines?
